Do Financial Conflicts of Interest Bias Research?
暂无分享,去创建一个
[1] R. Merton. Social Theory and Social Structure , 1958 .
[2] B. Martin. The Bias of Science , 1979 .
[3] Stephen Budiansky,et al. Ethics in science , 1985, Nature.
[4] Gary James Jason,et al. The Logic of Scientific Discovery , 1988 .
[5] J. Sacristán,et al. Evaluation of Pharmacoeconomic Studies: Utilization of a Checklist , 1993, The Annals of pharmacotherapy.
[6] P. Rochon,et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. , 1994, Archives of internal medicine.
[7] Jeffrey A. Johnson,et al. Evaluation of Published Pharmacoeconomic Studies , 1995 .
[8] G. Spilich,et al. Research into smoking or nicotine and human cognitive performance: does the source of funding make a difference? , 1997, Addiction.
[9] L. Bero,et al. Why review articles on the health effects of passive smoking reach different conclusions. , 1998, JAMA.
[10] M. Drummond,et al. Evaluating the BMJ guidelines for economic submissions: prospective audit of economic submissions to BMJ and The Lancet. , 1998, JAMA.
[11] S. Krimsky. Conflict of interest and cost-effectiveness analysis. , 1999, JAMA.
[12] M. Friedberg,et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. , 1999, JAMA.
[13] Alan Cantor,et al. The uncertainty principle and industry-sponsored research , 2000, The Lancet.
[14] B Djulbegovic,et al. Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] B. Knishkowy,et al. The association between funding by commercial interests and study outcome in randomized controlled drug trials. , 2001, Family practice.
[16] D. Moher,et al. Funding source, trial outcome and reporting quality: are they related? Results of a pilot study , 2002, BMC health services research.
[17] Norman G Levinsky,et al. Nonfinancial conflicts of interest in research. , 2002, The New England journal of medicine.
[18] Christian Gluud,et al. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? , 2003, JAMA.
[19] C. Gross,et al. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. , 2003, JAMA.
[20] Marcia Angell,et al. The Truth About the Drug Companies , 2004 .
[21] Sheldon Krimsky. THE FUNDING EFFECT IN SCIENCE AND ITS IMPLICATIONS FOR THE JUDICIARY , 2005 .
[22] W. Welshons,et al. Implications for human health of the extensive bisphenol A literature showing adverse effects at low doses: a response to attempts to mislead the public. , 2005, Toxicology.
[23] S. Krimsky. Rescuing Science from Politics: Publication Bias, Data Ownership, and the Funding Effect in Science: Threats to the Integrity of Biomedical Research , 2006 .
[24] Dan Greenberg,et al. Bias in published cost effectiveness studies: systematic review , 2006, BMJ : British Medical Journal.
[25] W. Welshons,et al. Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. , 2006, Environmental research.
[26] E. Richter,et al. Relationship between conflicts of interest and research results , 2007, Journal of General Internal Medicine.
[27] Rescuing Science From Politics: Regulation and the Distortion of Scientific Research , 2007 .
[28] J. Sugarman. Human stem cell ethics: beyond the embryo. , 2008, Cell stem cell.
[29] Modeling in pharmacoeconomic studies: Funding sources and outcomes , 2010, International Journal of Technology Assessment in Health Care.
[30] C. Peirce,et al. The Fixation of Belief , 2011, Philosophy after Darwin.
[31] Arjen van Dalen,et al. Structural Bias in Cross-National Perspective: How Political Systems and Journalism Cultures Influence Government Dominance in the News , 2012 .
[32] Evaluating the BMJ Guidelines for Economic Submissions , 2013 .